GGHC
MBII

Gilder Gagnon Howe & Co’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-297,076
Closed -$790K – 301
2014
Q3 		$790K Sell
297,076
-1,709,568
-85% -$11.4M 0.01% 218
2014
Q2 		$23.3M Sell
2,006,644
-1,081,679
-35% -$12.3M 0.31% 73
2014
Q1 		$43.1M Buy
3,088,323
+2,028,915
+192% +$31.9M 0.59% 55
2013
Q4 		$18.8M Buy
1,059,408
+123,734
+13% +$2.01M 0.27% 84
2013
Q3 		$15.8M Buy
+935,674
New +$13.1M 0.25% 85

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return

Gilder Gagnon Howe & Co's MBII Position: Q4 2014 in Review

Gilder Gagnon Howe & Co sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2014, closing a stake of 297,076 shares — an estimated $790K sold.

Gilder Gagnon Howe & Co first reported a position in MBII in Q3 2013 and held it in 5 quarters. The position peaked at $43.1M in Q1 2014. 37 funds tracked by Wall St. Rank hold MBII as of Q4 2014.

  • Gilder Gagnon Howe & Co reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2014 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 297,076 Marrone Bio Innovations, Inc. shares in Q4 2014, an estimated $790K.
  • Gilder Gagnon Howe & Co first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 5 quarters.
  • Gilder Gagnon Howe & Co's Marrone Bio Innovations, Inc. position peaked at $43.1M in Q1 2014.
  • 37 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2014.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2014, filed 13 Feb 2015.